相关实验视频
Updated: Jul 23, 2025
04:16
Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
12.9K
奥吉尔维综合征,心脏,以及神经
Asna Tasleem1, Adam Finkelstein2, Abdul Waheed1
1Family and Community Medicine, WellSpan Good Samaritan Hospital, Lebanon, PA, USA.
Clinical medicine insights. Case reports
|July 17, 2023
概括
奥吉尔维综合征 (ACPO) 是没有阻塞的结肠扩张. 尼奥斯蒂格明是一种治疗选择,但有禁忌. 这个案例探讨了在患有起器和心脏阻塞的患者中使用neostigmine的情况.
科学领域:
- 胃肠病学 胃肠病学
- 关键护理医学 关键护理医学
- 心脏病学 心脏病学
背景情况:
- 急性结肠伪阻塞 (ACPO) 或奥吉尔维综合征,涉及显著的结肠扩张.
- 在保守措施失败后,neostigmine是ACPO的常见药理干预措施.
- 尼奥斯蒂格明的使用带有潜在的心血管风险和禁忌.
研究的目的:
- 报告一个独特的病例,即在患有先前心脏病的患者中,为ACPO注射了neostigmine.
- 突出了neostigmine在心脏起器和心脏阻塞患者中的考虑因素和潜在风险.
主要方法:
- 病例报告详细介绍了ACPO的临床表现和管理.
- 审查患者的病史,重点关注心脏状况和心脏起器依赖性.
- 在重症监护室 (ICU) 设置中描述neostigmine的使用和患者监测.
主要成果:
- 这位患有ACPO的患者有症状的第一级心脏阻塞史,需要永久的心脏起器.
- 尼奥斯蒂格明用于ACPO管理的玻尿酸剂量.
- 密切监测患者对neostigmine的反应和任何相关的心血管事件.
结论:
- 在患有心脏起器和心脏阻塞的患者中,治疗ACPO的neostigmine治疗需要仔细考虑禁忌.
- 这一案例强调了在启动neostigmine治疗时个性化患者评估的重要性.
- 可能需要进一步调查,以确定在这种特定患者群体中使用neostigmine的安全协议.
相关概念视频
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
12
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
12
01:26Heart Failure Drugs: Inotropic Agents
633
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
633
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
460
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
460
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
719
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
719
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.1K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.1K